Pharma Journalist -

Takeda Pharmaceutical Company Limited announced that the European Commission (EC) extended the current marketing authorization of ALUNBRIG (brigatinib) to include use as a monotherapy…
Read More...

Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring and Takeda Pharmaceutical Company Limited to develop a potential plasma-derived therapy for treating…
Read More...

Servier, an independent international pharmaceutical company, announced that it has entered into a definitive agreement with the owners of Symphogen A/S, a leader in therapeutic…
Read More...

XBiotech Inc. and BioBridge Global announced their collaboration to participate in a U.S. Food and Drug Administration (FDA) investigational program for U.S. blood centers to begin…
Read More...

SMi Group reports: Pain Therapeutics conference will reconvene on 11th and 12 May by remote access. Regarding concerns over COVID-19 SMi’s 20th Annual Pain Therapeutics…
Read More...

AstraZeneca has completed the previously communicated agreement to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel, to RedHill Biopharma…
Read More...

Neurimmune AG and Ethris GmbH announced an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies administered by inhalation for the treatment of…
Read More...

Arena International announced today that the Temperature Controlled Logistics in Biopharmaceuticals Conference (https://arena-international.com/pharmatempusa/) will be held as a Virtual…
Read More...

Sorrento Therapeutics, Inc. announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren, New Jersey, based clinical-stage cell therapeutics company…
Read More...

Novartis announced plans to initiate a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi (ruxolitinib) for treatment of a type of severe immune…
Read More...